about
Tasquinimod (ABR-215050), a quinoline-3-carboxamide anti-angiogenic agent, modulates the expression of thrombospondin-1 in human prostate tumorsOverexpression of RRM2 decreases thrombspondin-1 and increases VEGF production in human cancer cells in vitro and in vivo: implication of RRM2 in angiogenesisProtein Kinase D1 Signaling in Angiogenic Gene Expression and VEGF-Mediated AngiogenesisUnderstanding the Biology of Bone Sarcoma from Early Initiating Events through Late Events in Metastasis and Disease ProgressionMechanism of action and clinical activity of tasquinimod in castrate-resistant prostate cancerMolecular basis of antiangiogenic thrombospondin-1 type 1 repeat domain interactions with CD36The aberrant methylation of TSP1 suppresses TGF-beta1 activation in colorectal cancer.Blockade of thrombospondin-1-CD47 interactions prevents necrosis of full thickness skin grafts.Genetic loci that control the size of laser-induced choroidal neovascularizationPhosphatase inhibitors with anti-angiogenic effect in vitroTumor suppressor U19/EAF2 regulates thrombospondin-1 expression via p53Platelet-derived growth factor regulates the secretion of extracellular vesicles by adipose mesenchymal stem cells and enhances their angiogenic potentialDiet-induced obesity links to ER positive breast cancer progression via LPA/PKD-1-CD36 signaling-mediated microvascular remodeling.Matrilin-1 is an inhibitor of neovascularization.Molecular mediators of angiogenesis.Changes in thrombospondin-1 levels in the endothelial cells of the anterior pituitary during estrogen-induced prolactin-secreting pituitary tumorsPlatelet-derived thrombospondin-1 is a critical negative regulator and potential biomarker of angiogenesis.Knock down of HIF-1alpha in glioma cells reduces migration in vitro and invasion in vivo and impairs their ability to form tumor spheres.Variable inhibition of thrombospondin 1 against liver and lung metastases through differential activation of metalloproteinase ADAMTS1.A double hit to kill tumor and endothelial cells by TRAIL and antiangiogenic 3TSR.Overexpression of the RNA binding protein HuR impairs tumor growth in triple negative breast cancer associated with deficient angiogenesis.Chronic delivery of a thrombospondin-1 mimetic decreases skeletal muscle capillarity in miceAngiogenesis in pituitary adenomas: human studies and new mutant mouse models.The molecular pathogenesis of osteosarcoma: a reviewInhibition of tumor-associated αvβ3 integrin regulates the angiogenic switch by enhancing expression of IGFBP-4 leading to reduced melanoma growth and angiogenesis in vivo.Lysophosphatidic acid suppresses endothelial cell CD36 expression and promotes angiogenesis via a PKD-1-dependent signaling pathway.Counterbalancing angiogenic regulatory factors control the rate of cancer progression and survival in a stage-specific manner.The thrombospondins.Quantitative proteomic analysis of meningiomas for the identification of surrogate protein markers.Thrombospondin-1 induction in the diabetic myocardium stabilizes the cardiac matrix in addition to promoting vascular rarefaction through angiopoietin-2 upregulation.Higher plasma thrombospondin-1 levels in patients with coronary artery disease and diabetes mellitus.Global proteome profiling of dental cementum under experimentally-induced apposition.Cell and molecular biology underpinning the effects of PEDF on cancers in general and osteosarcoma in particular.ABT-510 induces tumor cell apoptosis and inhibits ovarian tumor growth in an orthotopic, syngeneic model of epithelial ovarian cancer.Comparative proteome analysis of human epithelial ovarian cancer.Halofuginone mediated protection against radiation-induced leg contractureAssociation of Plasma Thrombospondin-1 Level with Cardiovascular Disease and Mortality in Hemodialysis Patients.CD47: a new target in cardiovascular therapy.LPA/PKD-1-FoxO1 Signaling Axis Mediates Endothelial Cell CD36 Transcriptional Repression and Proangiogenic and Proarteriogenic Reprogramming.Post-transcriptional gene regulation by HuR promotes a more tumorigenic phenotype.
P2860
Q21245714-66D924C0-F1D0-4A03-AD3A-4CC2DCE6E3EEQ21245720-531C3244-057E-4F38-B660-7AA8C5255FE4Q26747243-AB823A1A-EBF9-448D-BA53-4D70F56F51E8Q26829949-B2D9576D-8879-4EC0-B3CA-C6F8C6903A4EQ27024795-9BA29CC1-AFE2-4DC0-84CD-EA513C3A73E3Q29147397-35B105A6-EAC3-4A46-89A5-99C110C68592Q30491686-0E2E4E7C-B70D-47A0-98C6-F18892513434Q33312205-C1198139-8E0D-49B8-B6B3-FF55C79D51ACQ33411677-41465C57-26B4-42FB-B05D-FDEA5479A26BQ33588814-EDD67A16-5D40-49B7-A655-44BAB3988CE0Q33604141-EE4AD87A-F10A-41CA-AE49-C0D419074935Q33615922-73E882B4-9B44-4AC9-9314-D9A36DC9F31DQ33618393-3499A46F-28AB-4ADF-B8B9-C22DB39CDBFFQ33619544-929CEB94-B4AA-4B7A-BD69-1F62F8E2DB0CQ33639474-FE527522-0C31-4690-BAB1-5CFBFA1B08E1Q33849226-C778F022-7D2D-4D90-BDBA-15089C90E5BEQ33896683-A0B79397-5882-4D8B-B336-CC325895CCC1Q33961341-CE826397-5A08-4F74-8E08-7AAA4FEDBE31Q34108282-8F0A4A9F-9A9B-40EB-B1A8-2242C0042774Q34312127-E73D5158-87F0-4C6A-AE6F-1C3C193E1D7EQ34583152-F907B980-A027-4630-97D8-DABA8F4D1966Q34584625-7893B489-84B1-4B1A-8A17-C8C36BE3A019Q34611189-8B99D18C-3970-42CB-AB8E-5E1555D7AE17Q34629074-A4DF0D5C-805A-47D4-9091-AF97BB5569A2Q34799434-B5D99A72-BFBC-4338-BB80-E36086FB0922Q35037444-96E3A249-3DE3-4759-8CE9-7A44FF8D133AQ35049228-9E41BA39-A006-45CA-8CC9-A0F9DE6130B8Q35230013-48FE5AEE-226F-4B39-A30C-00C6F01635B9Q35440783-1ABBCAD6-DCF4-43A1-A109-D322CA2ED29AQ35534242-B359BA9C-969C-4AC3-A9BB-E91C40229CDEQ35794771-755A2DC2-8974-4C37-A5D7-A92C39C248DFQ35994425-7FA1CFC0-DFE9-4B5E-88D6-93B57C8E7FC8Q36011832-1A668A66-806D-43D6-AC7F-8A5CBBE2606DQ36060215-FC5BB5E9-9E79-4036-90C6-8FB6B79DA238Q36131119-02F667E6-8AEE-4724-A9EE-DCCCF738B7FFQ36393249-959EB842-D16A-495F-AF01-99130703772CQ36721458-844AB230-8957-4822-8574-916945BF6EF2Q36908751-F2544494-D03A-4B14-94AB-90A029E524ECQ36940630-746400DA-9F93-42FE-9566-77B57D2130A3Q36953651-7D0985D8-7133-4295-92A4-ECA307A3F137
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Regulation of tumor angiogenesis by thrombospondin-1.
@ast
Regulation of tumor angiogenesis by thrombospondin-1.
@en
type
label
Regulation of tumor angiogenesis by thrombospondin-1.
@ast
Regulation of tumor angiogenesis by thrombospondin-1.
@en
prefLabel
Regulation of tumor angiogenesis by thrombospondin-1.
@ast
Regulation of tumor angiogenesis by thrombospondin-1.
@en
P2093
P1476
Regulation of tumor angiogenesis by thrombospondin-1.
@en
P2093
Jack Lawler
Karen O Yee
Roya Khosravi-Far
P304
P356
10.1016/J.BBCAN.2005.11.002
P407
P577
2005-12-21T00:00:00Z